Oceanix Biotechnology

Oceanix Biotechnology, officially known as Qingdao Oceanix Biotechnology Co., Ltd., is a marine biotechnology company based in China that specializes in the research, development, and large-scale production of marine-derived biological materials. The company focuses on high-purity substances such as chitosan, glucosamine, and chondroitin sulfate, which are utilized in the pharmaceutical, nutraceutical, and cosmetic industries. Oceanix operates advanced manufacturing facilities that adhere to international quality standards, providing raw materials for wound care products and joint health supplements. Their business model integrates marine resource extraction with biotechnological processing to serve a global client base in the healthcare sector.